Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/71938
Title: | Thrombotic risk detection in patients with polycythemia vera: The predictive role of DNMT3A/TET2/ASXL1 mutations | Authors: | Segura-Díaz, Adrián Stuckey, Ruth Florido, Yanira González-Martín, Jesús María López-Rodríguez, Juan Francisco Sánchez-Sosa, Santiago González-Pérez, Elena Perdomo, María Nieves Sáez del Mar Perera, María de la Iglesia, Silvia Molero Labarta, María Teresa Gómez Casares, María Teresa Bilbao Sieyro, Cristina |
UNESCO Clasification: | 320703 Carcinogénesis | Keywords: | Cardiovascular Disease Myeloproliferative Neoplasms Next-Generation Sequencing Personalized Medicine Prognosis, et al |
Issue Date: | 2020 | Journal: | Cancers (Basel) | Abstract: | The development of thrombotic events is common among patients with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).We studied the influence of pathogenic mutations frequently associated with myeloid malignancies on thrombotic events using next-generation sequencing (NGS) in an initial cohort of 68 patients with myeloproliferative neoplasms (MPN). As expected, the presence of mutations in DNMT3A, TET2, and ASXL1 (DTAgenes) was positively associated with age for the whole cohort (p = 0.025, OR: 1.047, 95% CI: 1.006-1.090). Also, while not related with events in the whole cohort, DTA mutations were strongly associated with the development of vascular events in PV patients (p = 0.028). To confirm the possible association between the presence of DTA mutation and thrombotic events, we performed a case-control study on 55 age-matched patients with PV (including 12 PV patients from the initial cohort, 25 with event vs. 30 no event). In the age-matched case-control PV cohort, the presence of ≥1 DTAmutation significantly increased the risk of a thrombotic event (OR: 6.333, p = 0.0024). Specifically, mutations in TET2 were associated with thrombotic events in the PV case-control cohort (OR: 3.56, 95% CI: 1.15-11.83, p = 0.031). Our results suggest that pathogenic DTA mutations, and particularly TET2 mutations, may be an independent risk factor for thrombosis in patients with PV. However, the predictive value of TET2 and DTA mutations in ET and PMF was inconclusive and should be determined in a larger cohort. | URI: | http://hdl.handle.net/10553/71938 | ISSN: | 2072-6694 | DOI: | 10.3390/cancers12040934 | Source: | Cancers [EISSN 2072-6694], v. 12 (4), (Abril 2020) |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
40
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
36
checked on Oct 13, 2024
Page view(s)
141
checked on Aug 10, 2024
Download(s)
182
checked on Aug 10, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.